Tibet Duo Rui Pharmaceutical Co.Ltd. (301075.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China
Tibet Duo Rui Pharmaceutical Co.Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 240.63 m CNY | 154.18 m CNY |
| Gross profit | 102.06 m CNY | 12.60 m CNY |
| Operating income | -70.65 m CNY | -94.52 m CNY |
| EBIT | -77.87 m CNY | -113.42 m CNY |
| Net income | -62.67 m CNY | -102.17 m CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tibet Duo Rui Pharmaceutical Co.Ltd.
Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical formulations, chemical intermediates, and peptide APIs in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as multiple electrolytes injection; sodium acetate ringer's injection. Tibet Duo Rui Pharmaceutical Co., Ltd. was founded in 2005 and is headquartered in Tibet, China.
More stocks
- Yongtaiyun Chemical Logistics Co.Ltd (001228.SZ)
- Shenzhen Strongteam Decoration Engineering Co Ltd (002989.SZ)
- Ads-Tec Energy PLC (ADSE)
- Luyan Pharma Co Ltd (002788.SZ)
- Tuas Ltd (TUA.AX)
- Gold Royalty Corp (GROY)
- Zaptec ASA (ZAP.OL)
- Nyab AB (NYAB.ST)
- Qingdao Kutesmart Co Ltd (300840.SZ)
- CHOICEONE FINANCIAL SERVICES INC (COFS)
- Jiu Han System Technology Co. Ltd. (6903.TWO)
- MHA PLC (MHA.L)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.